Concepedia

Wei Liu

WL

Statistics

Publications

6

Citations

553

H-Index

6

Active since

2009

Affiliations

Novartis (Singapore)(Current)

Novartis (Switzerland)

Novartis (United States)

Novartis Institutes for BioMedical Research

Wei Liu is an author at Novartis (Singapore) specializing in life sciences, molecular virology, and medicinal chemistry.

ORCID

Publications per year

2009–2024

6

Publications

6

Cholesterol biosynthesis modulation regulates dengue viral replication

Christopher Rothwell, Aude LeBreton, Chuan Young Ng et al. · Virology · 2009 · 264 citations

, , +14

NITD-688, a pan-serotype inhibitor of the dengue virus NS4B protein, shows favorable pharmacokinetics and efficacy in preclinical animal models

Stephanie Moquin, Oliver Simon, Ratna Karuna et al. · Science Translational Medicine · 2021 · 93 citations

, , +17

Lead Optimization of Spiropyrazolopyridones: A New and Potent Class of Dengue Virus Inhibitors

Bin Zou, Wai Ling Chan, Mei Ding et al. · ACS Medicinal Chemistry Letters · 2015 · 72 citations

, , +17

Discovery of Tetrahydropyrazolopyrimidine Carboxamide Derivatives As Potent and Orally Active Antitubercular Agents

Fumiaki Yokokawa, Gang Wang, Wai Ling Chan et al. · ACS Medicinal Chemistry Letters · 2013 · 48 citations

, , +17

A Novel Anti-CD38 Monoclonal Antibody for Treating Immune Thrombocytopenia

Yunfei Chen, Yanmei Xu, Huiyuan Li et al. · New England Journal of Medicine · 2024 · 47 citations

, , +15

1–5 of 6